Accéder au contenu
Merck

Halopemide and benzodiazepine binding sites.

Archives internationales de pharmacodynamie et de therapie (1982-07-01)
A J Loonen, C J Soe-Agnie, W Soudijn
RÉSUMÉ

Halopemide inhibits 3H-BZ binding to crude and washed rat forebrain membranes with IC50 values of 16-25 microM. Its putative metabolites are considerably less active. The actions of halopemide are probably not directly related to its ability to interfere with high-affinity 3H-GABA binding sites. However, halopemide may have some unique properties in this regard.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Halopemide, ≥98% (HPLC)